Adam S Kibel

15PUBLICATIONS
99CO-AUTHORS
Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer diagnosisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Jul 30, 2025
Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer.

Hanna Zurl, Klara K Pohl, Stephan M Korn

|Apr 23, 2025
Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer.

Fu Gui, Baishan Jiang, Jie Jiang

|Nov 20, 2024
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling.

Yibai Zhao, Roman Gulati, Zhenwei Yang

|Oct 01, 2024
When is prostate cancer really cancer?

Matthew R Cooperberg, Avery E Braun, Alejandro Berlin

|Dec 02, 2023
Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancer.

Praful Ravi, Lucia Kwak, Wout Devlies

Pageof 3

Frequent Collaborators

2 joint publications

Eugene Cone

2 joint publications

Li Jia

2 joint publications

Takuya Tsujino

2 joint publications

Alexander P Cole